The intracellular redox state of alveolar cells is a determining factor for tolerance to oxidative and pro-inflammatory stresses. This study investigated the effects of intratracheal co-administration of antioxidants encapsulated in liposomes on the lungs of rats subjected to sepsis. For this, male rats subjected to sepsis induced by lipopolysaccharide from Escherichia coli or placebo operation were treated (intratracheally) with antibiotic, 0.9% saline and antioxidants encapsulated or non-encapsulated in liposomes. Experimental model of sepsis by cecal ligation and puncture (CLP) was performed in order to expose the cecum. The cecum was then gently squeezed to extrude a small amount of feces from the perforation site. As an index of oxidative damage, superoxide anions, lipid peroxidation, protein carbonyls, catalase activity, nitrates/nitrites, cell viability and mortality rate were measured. Infected animals treated with antibiotic plus antioxidants encapsulated in liposomes showed reduced levels of superoxide anion (54% or 7.650 ± 1.263 nmol/min/mg protein), lipid peroxidation (33% or 0.117 ± 0.041 nmol/mg protein), protein carbonyl (57% or 0.039 ± 0.022 nmol/mg protein) and mortality rate (3.3%), p value <0.001. This treatment also reduced the level of nitrite/nitrate and increased cell viability (90.7%) of alveolar macrophages. Taken togheter, theses results support that cationic liposomes containing antioxidants should be explored as coadjuvants in the treatment of pulmonary oxidative damage.
Introduction
The imbalance of intracellular redox status affects the signaling pathways responsible for cell proliferation, immune responses, bioenergetic metabolism, gene expression and cell death. This imbalance plays an important role in the pathogenesis of acute lung injury induced by generalized infection (Crimi et al., 2006 intracellular redox state of alveolar cells is a determining factor for tolerance to oxidative and pro-inflammatory stresses. Exposure to H 2 O 2 , tumor necrosis factor alpha (TNF-␣) or lipopolysaccharides (LPS) results in the decrease of tumor growth factor beta-1 (TGF-␤1), increased permeability of the alveolar-capillary barrier and increased cytokines (IL-1 and TNF-alpha) (Rahman et al., 2005) .
A strategy to limit injury of lung tissue would be to restore the alveolar redox balance (Kawabata et al., 2002) . Antioxidants can prolong the initiation phase or inhibit the propagation phase of reactive oxygen (ROS) and nitrogen species (RNS) and contribute to the prevention of pulmonary oxidative damage (Bhavsar et al., 2009; Mitsopoulos et al., 2008; Teixeira et al., 2008) . Despite being part of the diet, most antioxidants have poor bioavailability due to one or more factors such as poor solubility, instability during storage, first-pass effects or enzymatic degradation by the gastrointestinal tract (Ratnam et al., 2006) . Recently, the development of new liposomal systems (Ratnam et al., 2006) has been proposed in order to mitigate these losses when compared to conventional formulation systems (Epperly et al., 2002; Li et al., 2013) .
Based on this finds, we proposed investigated the effects of coadministration of antioxidants encapsulated into liposomes as a co-therapy in the treatment of respiratory tract infections. Therefore, our aim was to analyse the effects of inhaled co-administration of ascorbic acid, alpha-tocopherol and n-acetycysteine (NAC) encapsulated in liposomes into acute lung injury induced by sepsis.
Methods

Preparation of liposomes
Positively charged liposomes were prepared by the method of hydration of a lipid film (Lira et al., 2009) .Briefly, an assay was carried out with liposomes with 42 mM total lipids (phosphatidylcholine, cholesterol and stearylamine) at a molar ratio of 7:2:1 (w/w) to test the possibility of nanoencapsulating three antioxidants: vitamin C, N-acetylcysteine in the aqueous phase, and vitamin E in the organic phase. The following physicalchemical parameters of liposomal formulations were analyzed: pH, size (nm), polydispersity index (PDI), zeta potential (mV), molarity and stability of phase buffer. Then, to determine the best lipid concentrations of the organic phase of the liposomes, a complete 2 3 factorial design was performed with the following variables: phosphatidylcholine (0.179-0.298 mg), cholesterol (0.037-0.061 mg) and stearylamine (0.008-0.014 mg). In this assay, the following parameters were used for analysis of the results: size (nm), PDI, zeta potential (mV), pH and lipid peroxidation.
For the in vitro and in vivo studies the best formulation (F9) obtained from the factorial design described above was used. The formulation comprised the lipids (soybean phosphatidylcholine, cholesterol and stearylamine (in a molar ratio of 7:2:1) and 2 mg vitamin E dissolved in a mixture of CHCl 3 :MeOH (3:1 v/v), under magnetic stirring. The solvents were removed under pressure over 60 min (37 ± 1 • C, 80 rpm), resulting in the formation of a thin lipid film (organic phase). This film was then hydrated with 10 mL phosphate buffer solution to 0.15 M (aqueous phase), pH 7.4, containing 5 mg of vitamin C and 1 mg of N-acetylcysteine(NAC), resulting in multilamellar liposomes (NAC/VitC/VitE-lipo) described as Lip AO. The liposomal suspension was then sonicated (Vibra Cell, Branson, USA) at 200 W and 40 Hz for 300 s to form small unilamellar liposomes (Lira et al., 2009 ).
Characterization of liposomes
The pH of the liposome dispersions was measured with a glass electrode and a digital pH meter (Bioblock Scientific 99.622, Prolabo, Paris, France) at room temperature. The size diameter and polydispersity index of the liposomes was measured by photon correlation spectroscopy (Beckman Coulter Delsa TM Nano S particle analyzer) (Lira et al., 2009 ). The measurements were performed at 25 • C with a fixed angle of 90 • and the sizes were indicated as the average liposomal hydrodynamic diameter (nm). One hundred microliter (100 L) liposomes were diluted in 1 mL of ultrapure water. The zeta potential of the liposomes was used to analyse the surface charge of the vesicles (Zetasizer Nano ZS analyzer, Malvern) (Lira et al., 2009) .
Drug encapsulation efficiency was determined by the ultrafiltration/ultracentrifugation technique, using Ultrafree units (Millipore, USA, MW cut-off = 10,000 Da) (Cadena et al., 2013) . Samples of liposomes (400 L of formulation number 9) were inserted in filtration unit and submitted to ultracentrifugation at 8792g for 1 h, 4 • C (Eppendorf, model 5810R). Ten microliters of the sample that passed through the filter was diluted in 5 mL of methanol and the antioxidants encapsulated and non-encapsulated were quantified by UV spectrophotometry ( NAC = 203 nm; VitC = 245 nm; VitE = 210 nm). The contents of NAC, vitamin C and E were determined from standard curves prepared at concentratios form 0.25-1.5 g/mL.
For the long-term and accelerated stability testing, the methodology as described by Lira et al. was used (Lira et al., 2009) . After preparation, the samples of the liposomal suspension were subjected to centrifugation (3165g for 1 h at 4 • C) and horizontal mechanical stirring (180 beats/min for 48 h at 37 • C). To evaluate the long-term stability, the macroscopic appearance, pH change, particle size and polydispersity index (PDI) were monitored after preparation and during storage of lyophilized liposomal formulations at predetermined time intervals (0, 1, 3 and 9 days). Experimental model of sepsis by cecal ligation and puncture (CLP) was performed under aseptic conditions with male Wistar rats, aged 2-3 months. (n = 9 animals/group). Briefly, a 3-cm, midline laparotomy was performed in order to expose the cecum (Andrades et al., 2011) . The cecum was tightly ligated with a 3.0 silk suture at its base below the ileocecal valve, and pierced with a 14 gauge needle. The cecum was then gently squeezed to extrude a small amount of feces from the perforation site. A sham operation (laparotomy and cecal display, without any manipulation) was performed as a control. The animals were resuscitated with a normal saline solution (30 mL/kg, subcutaneously) immediately and after 12 h. After surgery, animals received "basic support" (saline, 50 mL/kg, and ceftriaxone, 30 mg/kg, intraperitoneally every 24 h for 5 consecutive days).
Administration of antioxidants encapsulated in liposomes
All the animals (n = 9 animals/group) were anesthetized with ketamine and xylazine (80 mg/kg and 15 mg/kg, respectively, at a dose of 0.2 mL/100 g, 1:1 v/v) and given, intratracheally (i.t.), 20 L of the following fresh formulations: empty liposomes; antioxidants-loaded liposome (NAC/Vit C/Vit E − liposome at 8 mg/mL of total antioxidants) or non-encapsulated antioxdiants (5 mg Vit C, 1 mg of NAC and 2 mg of vitamin E in 1 mL of ultrapure H 2 O). The formulations (F9) were administered through an ultrasonic membrane micronebulizer (MESH) (Arzu, 2014) for 20 s every 24 h for five consecutive days. At the end of the experiment, bronchoalveolar lavages were performed and then the animals were euthanized with an overdose of anesthetic (10% ketamine, 80 mg/kg; i.p.) for the removal of the lungs (Galvão et al., 2014) . The antioxidants doses were chosenbased on our previous study (Galvão et al., 2014) .
Analysis of superoxide anion
The levels of superoxide anion was measured according to the method proposed by Poderoso (Poderoso et al., 1996) . Submitochondrial particles (SMP) of the lungs (tissue) were isolated by differential centrifugation and the superoxide level was estimated by measuring adrenaline oxidation in a buffer containing succinate (used as an initiator of the electron transfer chain) and catalase. The color developed by the reaction was read spectrophotometrically at 780 nm and the result expressed in nmol/min/mg protein.
Determination of thiobarbituric acid reactive species (TBARS)
As an index of lipid peroxidation, a formation of TBARS was used during a warm-acid reaction, as described (Draper and Hadley, 1990) . The lungs (tissue) were homogenized in 50 mM phosphate buffer using a Potter-Elvehjem homogenizer. An aliquot (400 L) was mixed with 15% trichloroacetic acid (800 L) and centrifuged for 10 min (4000xg) and the supernatant mixed with an equal volume (500 L) of 0.67% thiobarbituric acid. This system was heated in a boiling water bath for 15 min and TBARS was determined by spectrophotometry at a wavelength of 535 nm. The protein concentration was measured by the Lowry assay and results were expressed as nmol of TBARS/mg protein (MDA equivalents).
Analysis of carbonyl groups
Oxidative damage to proteins was measured by the determination of carbonyl groups based on a reaction with dinitrophenylhydrazine (DNPH) (Levine et al., 1990) . Proteins were precipitated by the addition of 20% trichloroacetic acid and then react with DNPH. The samples were then redissolved in 6 M guanidine hydrochloride and the carbonyl content was determined by measuring the absorbance at 370 nm using a molar absorption coefficient of 22,000 M −1 .
Enzymatic activity of catalase
To determine the activity of catalase (CAT), the organs were homogenized in 50 mM phosphate buffer and the resulting suspension was centrifuged at 3000 xg for 10 min (Aebi, 1984) . The supernatant was used for the enzyme assay. CAT activity was measured by the rate of decrease in absorbance of hydrogen peroxide at 240 nm and expressed as U/mg protein, as described above.
Bronchoalveolar lavage
Bronchoalveolar lavage (BAL) fluid was obtained as described by De Castro (De Castro et al., 1995) . In the last experimental procedure (5th day), the animals were anesthetized, shaved in the upper anterior region of the neck and a dissection was performed to expose the trachea. Then, a cannula (aspiration probe number 6) was introduced into the trachea and six washes with 5 mL of saline were repeated. The collected fluid was centrifuged at 1600g for 10 min.
The BAL supernatant and cell pellet were stored in an ice bath and protected from light, until the beginning of the next stage.
Alveolar macrophage culture
The bronchoalveolar lavage was centrifuged at 3000 rpm, 4 • C for 10 min (Eppendorf, model 5810/5810 R). The cell pellet was washed and resuspended in culture medium containing RPMI 1640 (Gibco-Invitrogen Corporation) and 10% fetal bovine serum (FBS) (Gibco-Invitrogen Corporation) at a ratio of 9:1 v/v (de Melo et al., 2010) . The cell count was performed in a Neubauer chamber. Next, the cells were transferred to 6-well culture plates with a 35 mm diameter at a proportion of 1 × 10 6 cells/ml RPMI 1640 in each well and then cell viability steps (test MTT) or dosage of nitrites/nitrates were carried out. An aliquot of cells (8 × 10 6 ) was frozen. Cells were transfered into 2 mL Eppendorf tubes and stored in a freezer box containing isopropyl alcohol. In the process of freezing, in a −80 • C freezer, a cryoprotectant was used containing RPMI, FBS and DMSO at a ratio of 5:4:1 v/v with a final volume of 1 × 10 6 cells per ml of cryoprotectant.
Cell viability assay
The cell culture plate was removed from the oven (Sanyo ® , 37 • C and 5% CO 2 ) and the supernatant of each well was discarded. Then, the cell monolayer was washed with 1 mL of phosphate buffer at room temperature (0.01 M PBS, pH 7.02) and to the layer 550 L of PBS and 55 L of MTT solution (5 mg/mL) were added. The contents of the wells were homogenized and the plate wrapped in foil (to protect from light). The plate was incubated (34 • C and 5% CO 2 ) for 4 h in an oven under the same conditions, and afterwards 200 L of PBS and 200 L of DMSO (Sigma) were added. Then, the cell layer was removed from each well of the plate by a scraper. After this step, the material was transferred to Eppendorf tubes, wrapped in aluminum paper and stirred by vortexing. Subsequently, readings were made for each well of the material in a spectrophotometer, using a wavelength of 570 nm (Mosmann, 1983) . The results were expressed in percentage of viability of the wells compared to the control group. Approximately 1.0 × 10 6 cells/ml were incubated for 6 and 24 h with culture medium, LPS (100 ng/mL, administered volume 50 L), volume 100 L empty liposomes; antioxidants-loaded liposome; non-encapsulated; (8 mg/mL,) at different dilutions (1:1, 1:5, 1:10 and 1:50, v/v).
Analysis of nitrates/nitrites
Nitrite (NO 2 − ), a byproduct of the metabolism of nitric oxide, was measured using the Griess reaction (Ding et al., 1988) . Samples of 1 × 10 6 cells/ml/well were put to react with 50 L of 1% sulfanilamide solution for 10 min and mixed with 50 L of 0.1% solution of naphthyl ethylenediamine. The formation of stable azo compound of a purple color was measured spectrophotometrically by absorbance at 540 nm. The method was standardized with increasing concentrations of nitrite. Best formulation: Proportion of lipids in the organic phase: 7:2:1 + Vitamine E; Aqueous phase: Phosphate buffer 0.15 M, pH 7.4 + Vitamine C and n-acetylcysteine. a PC − phosphatidylcholine, CH − cholesterol, STA-stearylamine, -Zeta potential, pH-potential hydrogen. .
Survival
Survival was recorded over a 5-day period in a separate cohort. Rats submitted to CLP (sepsis) or placebo surgery (SHAM) were randomly divided (n = 6 animals per group) and received ceftriaxone plus N-acetylcysteine(NAC), ascorbic acid and alpha-tocopherol (vitamine C and E) or vehicle. In this cohort, blood samples were collected after surgery via catheter inserted into the tail for determination of plasmatic C reactive protein, (by turbidimetric immunoassay), Lactate dehydrogenase (by automated colorimetric system) and blood culture (by biochemistry analyzer − spectrophotometric system), as previously described (Table 1) (Price et al., 1987; Thorpe et al., 1990; Smolcic et al., 2011) .
Statistical analysis
Data were expressed as mean ± standard error (SEM)/standard deviation (SD). For the analysis of the survival curve, the KaplanMeier test was used and as a normality test the D'Agostino and Pearson test was used. The Kruska-Wallis test with Dunn's post-test was used for comparison between groups. All analyses were performed using GraphPad PRISM ® 4.03 program and values of p < 0.05 were considered statistically significant.
Results
Preparation and characterization of liposomes
The results shown in Tables 1 and 2 illustrate that the formulation (F9) with a 7:2:1 ratio of lipids in the organic phase + Vitamin E and 0.15 M phosphate buffer, pH 7.4 + Vitamin C and N-acetylcysteine in the aqueous phase, achieved the best physicalchemical parameters. The following physicochemical characteristics were used as responding variables: size, polydispersity index (PDI), zeta potential, pH and lipid peroxidation. This study was performed to develop formulations that present suitable vesicle sizes (<150 nm); low PDI (<0.300), which indicates good uniformity of vesicles; and highly charged surfaces (> 30 mV), which increases stability of the formulations and avoids aggregation. In addition, a pH close to physiological (pH 7.4) and low lipid peroxidation ensure the integrity of the antioxidants used in the preparation of formulations, and for this reason these parameters were also evaluated.
From this information, this study developed a complete 2 3 factorial design with varying concentrations of phosphatidylcholine, cholesterol and stearylamine and the best concentrations were used to make nanoscale formulations containing antioxidants: Vitamin E in the organic phase; and Vitamin C and n-acetylcysteine in the aqueous phase (Table 3 ). The stearylamine gave a charge to the vesicles. In view of this, the results shown in Table 3 demonstrate that formulation F9, in triplicate (9-11), showed suitable physicochemical characteristics. Data of antioxidants entrapment efficiency (EE%) of formulation (F9) are calculated using Eq. (1) and had a EE% close to 80% (79.26 ± 3.34%).
Superoxide anion
As shown in Fig. 1A , the placebo-treated group with empty liposomes or liposome-encapsulated antioxidants did not have altered levels of superoxide anion [ − O 2 ]. An increase of ten-fold in super- oxide anion occurred twenty-four hours after bacterial animal infection.The reduction of this damage was greater when animals were treated with antioxidants encapsulated in liposomes (54% for CLP/Lip AO and 22% in the CLP/AO group when compared to the control CLP, [ − O 2 ] = 7.650 ± 1.263 nmol/min/mg protein), p < 0.05.
Lipid peroxidation
The effect of co-administration of antioxidants reduced lipid damage (TBARS) after bacterial infection (Fig. 1B) . The concentrations of TBARS were reduced after administration of unloaded antioxidants (CLP/AO) and when treated with antioxidantencapsulated liposomes this reduction was 33% in the CLP/Lip AO (Eq. of MDA = 0.077 ± 0.022 nmol/mg protein) compared to the control CLP (Eq. of MDA = 0.117 ± 0.041 nmol/mg protein), pvalue < 0.05.
Protein carbonyl content
Carbonyl levels increased five-fold in the lungs of infected animals (CLP) in relation to the placebo operation (Fig. 1C) . This damage to proteins was reduced by 24% following treatment with free antioxidants (CLP/Lip AO). The reduction of this damage was greater when the infected animals received the co-administration of antioxidants encapsulated in liposomes (57% in the CLP/Lip AO, [carbonyl] = 0.039 ± 0.022 nmol/mg protein, group in relation to the CLP control group, [carbonyl] = 0.092 ± 0.011 nmol/mg protein), p-value < 0.05.
Enzymatic activity of catalase
Catalase activity increased 2.5 fold in the lungs of infected animals (CLP) relative to the placebo-operated (SHAM) group. However, catalase activity decreased by 16% in infected animals treated with unloaded antioxidants (CLP/AO). Furthermore, this reduction was greater when animals were treated with antioxidants encapsulated in liposomes (40% in CLP/Lip AO group compared to the CLP control group, Fig. 1D ), p-value < 0.05.
Levels of nitrate/nitrite and cell viability of alveolar macrophages
The production of nitrates/nitrites increased 2 fold in alveolar macrophage cultures stimulated with E. coli endotoxin (LPS), Fig. 2A . However, there was a reduction in the levels of nitrates/nitrites when liposomes were added to culture wells containing vitamins C and E (23%) or NAC alone (13%). This reduction was even greater when liposomes containing a combination of vitamins C, E and NAC were added. Cell viability decreased 26% when cells were stimulated with LPS and empty liposomes. However, this reduction in cell viability was attenuated when the cells were stimulated with vitamin E, NAC or vitamin C. This attenuation was greater still when the antioxidants were encapsulated in liposomes (Vitamin E 84.3%, NAC 80.6%, vitamin C 89.8% and NAC + E + C 90.7%) (Fig. 2B) , p-value < 0.05.
Survival
The results of the animal survival experiments are shown in Fig. 3 . Infected animals not receiving antibiotic therapy with ceftriaxone (CLP/control) died before the end of the third day. The survival rate was 80% in rats treated with ceftriaxone and unloaded antioxidants (CLP/AO), and 83.3% in the animals treated with ceftriaxone and antioxidants encapsulated in liposomes (CLP/Lip AO). Comparison of survival curves showed a Chi-square of 44.68 and p-value < 0.001. All animals survived in the placebo-operated group (SHAM). In this study, the surviving infected animals treated with ceftriaxone associated with antioxidant-liposome showed a decrease in markers of oxidative damage. 
Discussion
Redox imbalance plays an important role in the pathogenesis of acute lung injury (ALI).
[1] Patients with ALI-induced respiratory infections show a significant decrease in the concentrations of antioxidants, such as N-acetyl cysteine, ascorbic acid, tocopherol, glutathione, ␤-carotene and selenium (Bowler et al., 2003; Richard et al., 1990 ). Given the above, this paper proposes an innovative product using nanoscale, inhaled, pharmaceutical formulations able to limit injury to lung tissue and restore the redox balance of the affected alveolar cells. This paper describes a formulation of liposomal vesicles at the nanoscale which is able to protect bioactive compounds from degradation and maintains a controlled release after administration.
According to Ratnam et al., in general antioxidants have low bioavailability due to one or more factors such as poor solubility, difficult permeability, instability during storage, first-pass effects or enzymatic degradation by the gastrointestinal tract or by plasma enzymes. Suntres and Shek (1998) and Smith et al. (1992) have shown that when antioxidants such as glutathione (GSH), are administered intratracheally, only 1% to 2% of the administered dose remains in the lungs after 24 h, whereas when encapsulated by nanomaterials retention is 18% of the dose in the first 24 h.
Some studies (Parnham and Wetzig, 1993; Knight and Roberts, 1985; Hidiroglou et al., 1988) and patents (WO2001003669, US1990/4898735 and US2014/0141066) reported that the administration separately of ascorbic acid, tocopherol or N-acetylcysteine encapsulated into liposomesresulted in controversial effects in terms of preventing lung damage. As example, Fan et al. (2000) showed that the formulation of N-acetylcysteine encapsulated into liposomes is more effective than isolated for attenuating oxidative damage to lungs induced by Escherichia coli endotoxin. However, the administration of L-NAC (25 mg/kg intravenously alone) was not capable of mitigating lesion severity, particularly when lung disease was in an advanced stage.
In our model of sepsis, the results show that co-administration of ceftriaxone and antioxidants (NAC, vitamin C and E) encapsulated in liposomes was the best way to reduce pulmonary damage induced by sepsis. This combination therapy significantly reduced the production of superoxide anions, lipid peroxidation, the formation of carbonyl groups and the mortality of animals. In addition, it attenuated the enzymatic activity of catalase and contributed to the restoration of the redox state in the lung.
Intratracheal administration produced high levels of liposomeencapsulated ␣-tocopherol in lungs (1 mg/g) (Thomas et al., 1991) when compared to oral or parenteral administrations (40 g/g of lung tissue) (Eichler et al., 1988; Storm et al., 1991) . Inhalation of liposomes composed only of lipids (at concentrations of 15 and 150 mg/mL dipalmitoylphosphatidylcholine, DPPC) for 1 h in healthy, non-smoking volunteers, has shown that inhalation of liposomes is well tolerated, does not induce oxygen desaturation, does not affect lung function or cause side effects (Thomas et al., 1991) . Studies using liposomes tagged with fluorescein examined their clearance rate from lungs in volunteers and observed no side effects (Srinath et al., 2000 Suntres and Shek, 1994) . Storm et al. (1991) conducted studies and demonstrated that intravenous administration of DPPC (5-50 mg) did not induce acute or delayed toxicity in mice after two weeks of treatment (Storm et al., 1991) . The toxicity of liposomes consisting of DPPC, administered intravenously, is considered low, the LD50 value is estimated at 10 g/kg in mice (Storm et al., 1991) .
In our in vitro assays, the culture of alveolar macrophages stimulated with LPS and co-adjuvant therapy reduced the levels of nitrates/nitrites and increased the cellular viability of alveolar macrophages. Interestingly, there is evidence that ␣-tocopherol acetate inhibits the activation of nuclear factor ␤ (NF-␤) in alveolar macrophage cultures (Nakamura et al., 1996) . NF-␤ is a transcription factor that regulates the expression of many proinflammatory cytokines. The balance of the intracellular redox state of alveolar cells is a determining factor for tolerance to oxidative damage (Nakamura et al., 1996) .
Exposure to the lipopolysaccharide (LPS) from E. coli resulted in decreased tumor growth factor beta-1 (TGF-␤1), increased permeability of the alveolar-capillary barrier and increased proinflammatory cytokines such as IL-1 and TNF-alpha in alveolar cells (Rahman et al., 2005; Batista et al., 2007) . Our in vitro results demonstrated that intratracheal administration of NAC associated with ascorbic acid and tocopherol encapsulated into liposomes increased alveolar antioxidant activity and protected alveolar cells against pulmonary oxidative damage after infection induced by E. coli.
Yao et al. showed that intravenous administration of tocopherol esters (TOH) encapsulated in liposomes decreased the mortality of mice after a lethal dose of carbon tetrachloride (CCl 4 ) (Yao et al., 1994) . However, these formulations of liposomes containing TOH accumulate mainly in the Kupffer cells of the liver and poorly in the lungs (Yao et al., 1994) . Once in pulmonary tissue, tocopherol esters must first be esterified by enzymes (esterases) present in the intestinal tract, so that unesterified tocopherol can be released to carry out its biological activity.
In the present study, the results showed that none of the infected animals without antibiotic therapy survived to the third day. At the end of the fifth day, the survival of animals infected and treated with ceftriaxone and free antioxidants (CLP/AO) was 80%, a value which increased to 83.3% when animals were treated with ceftriaxone and antioxidants encapsulated in liposomes (CLP/Lip AO, Chi-square of 44.68 and p value <0.001). This can be explained by the fact that when antioxidants are administered intratracheally and encapsulated in liposomes, there is increased dose retention in the lungs, as the liposomes act as a controlled-release system. According some authors (Knudsen et al., 2015; Dokka et al., 2000; Shah et al., 2013) , cationic liposomes at high doses showed toxicological effects (DNA damage and oxidative injury), whereas lower doses produced limited effects. These toxicological effects are probably related to the cationic surface charge (high potential zeta, more than 50.0 mV) and with the use of synthetic lipids (DOTAP). In order to minimize this risk (Galvão et al., 2011) , we used, in this study, cationic liposomes with lower potential zeta (34.50 ± 1.95 mV) and natural lipids (phosphatidylcholine, cholesterol and stearylamine).
Conclusions
Co-administration of ceftriaxone associated with NAC and vitamins C and E encapsulated in liposomes reduced lung injury induced by sepsis and increased survival rate in rats. Although acute lung injury and sepsis present mechanisms of injury caused by free radicals, these mechanisms are not the only ones. In this way, our results suggest that antioxidants could play an important role as co-adjuvant in the treatment of respiratory infections.
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Originality and clinical relevance
In the present study, the potential clinical applicability of encapsulation of antioxidants in liposomes is investigated for mitigation of pulmonary injury and alveolar macrophage death by free-radical-related mechanisms. This co-administration significantly reduced pulmonary damage by decreasing superoxide anion production, lipid peroxidation, protein carbonyls, and improved survival.
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